Carotid magnetic resonance imaging for monitoring atherosclerotic plaque progression: a multicenter reproducibility study

International Journal of Cardiovascular Imaging

Volumn 31, Issue 1, 2015, Pages 95-103

  Sun, Jie ^a   Zhao, Xue Qiao ^a   Balu, Niranjan ^a   Hippe, Daniel S ^a   Hatsukami, Thomas S ^a   Isquith, Daniel A ^a   Yamada, Kiyofumi ^a   Neradilek, Moni B ^c   Cantón, Gádor ^b   Xue, Yunjing ^a   Fleg, Jerome L ^d   Desvigne Nickens, Patrice ^d   Klimas, Michael T ^e   Padley, Robert J ^f   Vassileva, Maria T ^g   Wyman, Bradley T ^h   Yuan, Chun ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b University of Washington   (United States)

^c Mountain Whisper Light Statistics   (United States)

^d NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^e MERCK RESEARCH LABORATORIES   (United States)

^f ABBVIE INC   (United States)

^g NATIONAL INSTITUTES OF HEALTH   (United States)

^h PFIZER INC   (United States)

Author keywords

Atherosclerosis; Carotid artery; Magnetic resonance imaging; Multicenter study; Reproducibility

Indexed keywords

GADOLINIUM PENTETATE MEGLUMINE; LIPID;

ADULT; ARTICLE; ATHEROSCLEROTIC PLAQUE; CALCIFICATION; CAROTID ARTERY; CLINICAL PROTOCOL; CONTRAST ENHANCEMENT; DISEASE COURSE; FEMALE; HUMAN; IMAGE QUALITY; MAJOR CLINICAL STUDY; MALE; MEASUREMENT ERROR; MEASUREMENT PRECISION; MORPHOLOGY; MULTICENTER STUDY; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; QUANTITATIVE ANALYSIS; REPRODUCIBILITY; TISSUE NECROSIS; VOLUMETRY; AGED; BLOOD VESSEL CALCIFICATION; CANADA; CAROTID ARTERY DISEASE; CHEMISTRY; CHINA; CLINICAL TRIAL; COMPARATIVE STUDY; COMPUTER ASSISTED DIAGNOSIS; DEVICES; EQUIPMENT DESIGN; EVALUATION STUDY; FEASIBILITY STUDY; FIBROSIS; MAGNETIC RESONANCE ANGIOGRAPHY; METABOLISM; MIDDLE AGED; NECROSIS; OBSERVER VARIATION; PATHOLOGY; PREDICTIVE VALUE; PROSPECTIVE STUDY; TIME; UNITED STATES; VERY ELDERLY;

AGED; AGED, 80 AND OVER; CANADA; CAROTID ARTERIES; CAROTID ARTERY DISEASES; CHINA; DISEASE PROGRESSION; EQUIPMENT DESIGN; FEASIBILITY STUDIES; FEMALE; FIBROSIS; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; LIPIDS; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; MIDDLE AGED; NECROSIS; OBSERVER VARIATION; PLAQUE, ATHEROSCLEROTIC; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; REPRODUCIBILITY OF RESULTS; TIME FACTORS; UNITED STATES; VASCULAR CALCIFICATION;

EID: 84921029307     PISSN: 15695794     EISSN: 15730743     Source Type: Journal    
DOI: 10.1007/s10554-014-0532-7     Document Type: Article

References (33)

1. Corti R, Fayad ZA, Fuster V, Worthley SG, Helft G, Chesebro J, Mercuri M, Badimon JJ (2001) Effects of lipid-lowering by simvastatin on human atherosclerotic lesions: a longitudinal study by high-resolution, noninvasive magnetic resonance imaging. Circulation 104:249–252
2. Lima JA, Desai MY, Steen H, Warren WP, Gautam S, Lai S (2004) Statin-induced cholesterol lowering and plaque regression after 6 months of magnetic resonance imaging-monitored therapy. Circulation 110:2336–2341
3. Yonemura A, Momiyama Y, Fayad ZA, Ayaori M, Ohmori R, Higashi K, Kihara T, Sawada S, Iwamoto N, Ogura M, Taniguchi H, Kusuhara M, Nagata M, Nakamura H, Tamai S, Ohsuzu F (2005) Effect of lipid-lowering therapy with atorvastatin on atherosclerotic aortic plaques detected by noninvasive magnetic resonance imaging. J Am Coll Cardiol 45:733–742
4. Lee JM, Wiesmann F, Shirodaria C, Leeson P, Petersen SE, Francis JM, Jackson CE, Robson MD, Neubauer S, Channon KM, Choudhury RP (2008) Early changes in arterial structure and function following statin initiation: quantification by magnetic resonance imaging. Atherosclerosis 197:951–958
5. Underhill HR, Yuan C, Zhao XQ, Kraiss LW, Parker DL, Saam T, Chu B, Takaya N, Liu F, Polissar NL, Neradilek B, Raichlen JS, Cain VA, Waterton JC, Hamar W, Hatsukami TS (2008) Effect of rosuvastatin therapy on carotid plaque morphology and composition in moderately hypercholesterolemic patients: a high-resolution magnetic resonance imaging trial. Am Heart J 155:581–584
6. Boussel L, Arora S, Rapp J, Rutt B, Huston J, Parker D, Yuan C, Bassiouny H, Saloner D (2009) Atherosclerotic plaque progression in carotid arteries: monitoring with high-spatial-resolution MR imaging–multicenter trial. Radiology 252:789–796
7. Zhao XQ, Dong L, Hatsukami T, Phan BA, Chu B, Moore A, Lane T, Neradilek MB, Polissar N, Monick D, Lee C, Underhill H, Yuan C (2011) MR imaging of carotid plaque composition during lipid-lowering therapy: a prospective assessment of effect and time course. J Am Coll Cardiovasc Imaging 4:977–986
8. Sun J, Balu N, Hippe DS, Xue Y, Dong L, Zhao X, Li F, Xu D, Hatsukami TS, Yuan C (2013) Subclinical carotid atherosclerosis: short-term natural history of lipid-rich necrotic core–a multicenter study with MR imaging. Radiology 268:61–68
9. Fayad ZA, Mani V, Woodward M, Kallend D, Abt M, Burgess T, Fuster V, Ballantyne CM, Stein EA, Tardif JC, Rudd JH, Farkouh ME, Tawakol A (2011) Safety and efficacy of dalcetrapib on atherosclerotic disease using novel non-invasive multimodality imaging (dal-PLAQUE): a randomised clinical trial. Lancet 378:1547–1559
10. Kawahara T, Nishikawa M, Kawahara C, Inazu T, Sakai K, Suzuki G (2013) Atorvastatin, etidronate, or both in patients at high risk for atherosclerotic aortic plaques: a randomized, controlled trial. Circulation 127:2327–2335
11. Cai JM, Hatsukami TS, Ferguson MS, Kerwin WS, Saam T, Chu BC, Takaya N, Polissar NL, Yuan C (2005) In vivo quantitative measurement of intact fibrous cap and lipid-rich necrotic core size in atherosclerotic carotid plaque: comparison of high-resolution, contrast-enhanced magnetic resonance imaging and histology. Circulation 112:3437–3444
12. Trivedi RA, U-King-Im JM, Graves MJ, Horsley J, Goddard M, Kirkpatrick PJ, Gillard JH (2004) MRI-derived measurements of fibrous-cap and lipid-core thickness: the potential for identifying vulnerable carotid plaques in vivo. Neuroradiology 46:738–743
13. Cappendijk VC, Heeneman S, Kessels AG, Cleutjens KB, Schurink GW, Welten RJ, Mess WH, van Suylen RJ, Leiner T, Daemen MJ, van Engelshoven JM, Kooi ME (2008) Comparison of single-sequence T1w TFE MRI with multisequence MRI for the quantification of lipid-rich necrotic core in atherosclerotic plaque. J Magn Reson Imaging 27:1347–1355
14. Alizadeh DR, Doornbos J, Tamsma JT, Stuber M, Putter H, van der Geest RJ, Lamb HJ, de Roos A (2007) Assessment of the carotid artery by MRI at 3T: a study on reproducibility. J Magn Reson Imaging 25:1035–1043
15. Syed MA, Oshinski JN, Kitchen C, Ali A, Charnigo RJ, Quyyumi AA (2009) Variability of carotid artery measurements on 3-Tesla MRI and its impact on sample size calculation for clinical research. Int J Cardiovasc Imaging 25:581–589
16. Duivenvoorden R, de Groot E, Elsen BM, Lameris JS, van der Geest RJ, Stroes ES, Kastelein JJ, Nederveen AJ (2009) In vivo quantification of carotid artery wall dimensions: 3.0-Tesla MRI versus B-mode ultrasound imaging. Circ Cardiovasc Imaging 2:235–242
17. Reig S, Sánchez-González J, Arango C, Castro J, González-Pinto A, Ortuño F, Crespo-Facorro B, Bargalló N, Desco M (2009) Assessment of the increase in variability when combining volumetric data from different scanners. Hum Brain Mapp 30:355–368
18. Saam T, Hatsukami TS, Yarnykh VL, Hayes CE, Underhill H, Chu BC, Takaya N, Cai JM, Kerwin WS, Xu DX, Polissar NL, Neradilek B, Hamar WK, Maki J, Shaw DW, Buck RJ, Wyman B, Yuan C (2007) Reader and platform reproducibility for quantitative assessment of carotid atherosclerotic plaque using 1.5T Siemens, Philips, and General Electric scanners. J Magn Reson Imaging 26:344–352
19. The AIM-HIGH Investigators (2011) The role of niacin in raising high-density lipoprotein cholesterol to reduce cardiovascular events in patients with atherosclerotic cardiovascular disease and optimally treated low-density lipoprotein cholesterol Rationale and study design. The Atherothrombosis Intervention in Metabolic syndrome with low HDL/high triglycerides: impact on Global Health outcomes (AIM-HIGH). Am Heart J 161:471–477
20. Balu N, Yarnykh VL, Scholnick J, Chu BC, Yuan C, Hayes C (2009) Improvements in carotid plaque imaging using a new eight-element phased array coil at 3T. J Magn Reson Imaging 30:1209–1214
21. Kerwin WS, Xu D, Liu F, Saam T, Underhill HR, Takaya N, Chu BC, Hatsukami TS, Yuan C (2007) Magnetic resonance imaging of carotid atherosclerosis: plaque analysis. Top Magn Reson Imaging 18:371–378
22. Liu F, Xu DX, Ferguson MS, Chu BC, Saam T, Takaya N, Hatsukami TS, Yuan C, Kerwin WS (2006) Automated in vivo segmentation of carotid plaque MRI with morphology-enhanced probability maps. Magn Reson Med 55:659–668
23. Cohen J (1960) A coefficient of agreement for nominal scales. Educ Psychol Meas 20:37–46
24. Pinheiro JC, Bates DM (2000) Mixed-effects models in S and S-PLUS. Springer, New York, NY
25. Friedman L, Glover GH (2006) Report on a multicenter fMRI quality assurance protocol. J Magn Reson Imaging 23:827–839
26. Vidal A, Bureau Y, Wade T, Spence JD, Rutt BK, Fenster A, Parraga G (2008) Scan-rescan and intra-observer variability of magnetic resonance imaging of carotid atherosclerosis at 1.5 T and 3.0 T. Phys Med Biol 53:6821–6835
27. Saam T, Kerwin WS, Chu BC, Cai JM, Kampschulte A, Hatsukami TS, Zhao XQ, Polissar NL, Neradilek B, Yarnykh VL, Flemming K, Huston J, Insull W, Morrisett JD, Rand SD, Demarco KJ, Yuan C (2005) Sample size calculation for clinical trials using magnetic resonance imaging for the quantitative assessment of carotid atherosclerosis. J Cardiovasc Magn Reson 7:799–808
28. Li F, Yarnykh VL, Hatsukami TS, Chu B, Balu N, Wang J, Underhill HR, Zhao X, Smith R, Yuan C (2010) Scan-rescan reproducibility of carotid atherosclerotic plaque morphology and tissue composition measurements using multicontrast MRI at 3T. J Magn Reson Imaging 31:168–176
29. Wasserman BA, Astor BC, Sharrett AR, Swingen C, Catellier D (2010) MRI measurements of carotid plaque in the atherosclerosis risk in communities (ARIC) study: methods, reliability and descriptive statistics. J Magn Reson Imaging 31:406–415
30. Takaya N, Cai JM, Ferguson MS, Yarnykh VL, Chu BC, Saam T, Polissar NL, Sherwood J, Cury RC, Anders RJ, Broschat KO, Hinton D, Furie KL, Hatsukami TS, Yuan C (2006) Intra- and interreader reproducibility of magnetic resonance imaging for quantifying the lipid-rich necrotic core is improved with gadolinium contrast enhancement. J Magn Reson Imaging 24:203–210
31. Touze E, Toussaint JF, Coste J, Schmitt E, Bonneville F, Vandermarcq P, Gauvrit JY, Douvrin F, Meder JF, Mas JL, Oppenheim C (2007) Reproducibility of high-resolution MRI for the identification and the quantification of carotid atherosclerotic plaque components: consequences for prognosis studies and therapeutic trials. Stroke 38:1812–1819
32. Kerwin WS, Liu F, Yarnykh V, Underhill H, Oikawa M, Yu W, Hatsukami TS, Yuan C (2008) Signal features of the atherosclerotic plaque at 3.0 Tesla versus 1.5 Tesla: Impact on automatic classification. J Magn Reson Imaging 28:987–995
33. Liu W, Balu N, Sun J, Zhao X, Chen H, Yuan C, Zhao H, Xu J, Wang G, Kerwin WS (2012) Segmentation of carotid plaque using multicontrast 3D gradient echo MRI. J Magn Reson Imaging 35:812–819